Tracking gradual changes helps identify degradation progression before complete loss of potency
BPC-157 + GHK-Cu For skin healing, wound recovery, or post-procedure recovery, adding GHK-Cu to BPC-157 gives you a solid one-two punch
Ortega RA, Wang C, Raymond D et al (2021) Association of dual LRRK2 G2019S and GBA variations with Parkinson disease progression
Results from these products are unpredictable, and side effects from contaminants are a real risk
Hepatic Metabolism and MASLD The glucagon receptor is highly expressed in the liver, and Phase 2 imaging data suggests retatrutide produces dramatic reductions in hepatic fat
Week 1 experiment: Administer DSIP 3 hours before intended sleep Track time to fall asleep, sleep quality, morning alertness Note any grogginess or sleep disturbance Week 2 experiment: Administer DSIP 1.5 hours before intended sleep Track the same variables Compare results to week 1 Week 3 experiment: Administer DSIP 30-45 minutes before intended sleep Track and compare Identify which timing produced the best results Some users find their optimal timing changes over a cycle